Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8TM7

Human NAMPT in complex with substrate NAM and small molecule activator NP-A3

Summary for 8TM7
Entry DOI10.2210/pdb8tm7/pdb
DescriptorNicotinamide phosphoribosyltransferase, GLYCEROL, NICOTINAMIDE, ... (7 entities in total)
Functional Keywordsnad+ aging enzyme activation, transferase
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight114883.99
Authors
Ratia, K.M.,Thatcher, G.R. (deposition date: 2023-07-28, release date: 2024-06-12)
Primary citationGordon-Blake, J.,Ratia, K.,Weidig, V.,Velma, G.R.,Ackerman-Berrier, M.,Penton, C.,Musku, S.R.,Alves, E.T.M.,Driver, T.,Tai, L.,Thatcher, G.R.J.
Nicotinamide Phosphoribosyltransferase Positive Allosteric Modulators Attenuate Neuronal Oxidative Stress.
Acs Med.Chem.Lett., 15:205-214, 2024
Cited by
PubMed Abstract: Evidence supports boosting nicotinamide adenine dinucleotide (NAD) to counteract oxidative stress in aging and neurodegenerative disease. One approach is to enhance the activity of nicotinamide phosphoribosyltransferase (NAMPT). Novel NAMPT positive allosteric modulators (N-PAMs) were identified. A cocrystal structure confirmed N-PAM binding to the NAMPT rear channel. Early hit-to-lead efforts led to a 1.88-fold maximum increase in the level of NAD in human THP-1 cells. Select N-PAMs were assessed for mitigation of reactive oxygen species (ROS) in HT-22 neuronal cells subject to inflammatory stress using tumor necrosis factor alpha (TNFα). N-PAMs that increased NAD more effectively in THP-1 cells attenuated TNFα-induced ROS more effectively in HT-22 cells. The most efficacious N-PAM completely attenuated ROS elevation in glutamate-stressed HT-22 cells, a model of neuronal excitotoxicity. This work demonstrates for the first time that N-PAMs are capable of mitigating elevated ROS in neurons stressed with TNFα and glutamate and provides support for further N-PAM optimization for treatment of neurodegenerative diseases.
PubMed: 38352833
DOI: 10.1021/acsmedchemlett.3c00391
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.79 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon